ARCHIVES

DCT Faces Hard Choices, Clinical Group Need Re-Examination, Chabner tells BSC

This article is from The Cancer Letter archive.

Vol. 08 No. 44 | November 12, 1982

Download PDF Visit The Full Archive

Related Articles

Vogel To Succeed Yates As VP for Research At American Cancer Society.

October 17, 2008

Kyprolis Demonstrates Overall Response Following FDA Accelerated Approval

August 31, 2012

Genentech: ODAC Lacks Expertise, Impartiality; FDA: Company’s Proposal Unscientific

August 12, 2011

CCIRC Holds Groups To 1980 Spending Levels, But They May Get Even Less

January 9, 1981

NCI Launches NCORP with 53 Grants Totaling $465 Million

August 8, 2014

HHS Carcinogen Guidelines For Labs Could Apply To Other

May 30, 1980